Table 2 Reasons for discontinuation of onabotulinumtoxinA treatment (n = 9)
| Reasons for discontinuation of Onabotulinumtoxin-A treatment | N (%) |
|---|---|
| Lost to follow-up | 3 (33.3%) |
| Financial limitations | 1 (11.1%) |
| Patients significantly improved/ No additional sessions were needed | 5 (55.5%) |
